Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease located below the knee, following the implant’s approval by the FDA ...

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a late ...

The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee ... Esprit BTK's potential to revolutionize the treatment of peripheral artery disease below the knee," said ...